TY - JOUR
T1 - Antenatal glucocorticoids reduce growth in appropriately grown and growth-restricted ovine fetuses in a sex-specific manner
AU - Miller, Suzanne Lee
AU - Sutherland, Amy Elizabeth
AU - Supramaniam, Veena Gayathri
AU - Walker, David William
AU - Jenkin, Graham
AU - Wallace, Euan Morrison
PY - 2012
Y1 - 2012
N2 - Antenatal glucocorticoids are administered to mature the fetal lungs before preterm birth. Glucocorticoids also have non-pulmonary effects, including reducing fetal body and brain growth. The present study examined whether glucocorticoid administration has a sex-specific effect on growth in appropriately grown (control) and intrauterine growth-restricted (IUGR) fetal sheep. IUGR was induced at 0.7 gestation in fetal sheep by single umbilical artery ligation. On Days 5 and 6 after surgery, IUGR or control fetuses were exposed to the synthetic glucocorticoid betamethasone (BM; 11.4mg) or saline via intramuscular maternal administration. On Day 7, a postmortem was conducted to determine fetal sex and weight. Compared with control fetuses, the birthweight of male and female IUGR fetuses was significantly reduced (by 18.5+/-4.4 (P=0.002) and 21.7+/-6.0 (P=0.001), respectively). Maternal administration of BM significantly reduced bodyweight in both control and IUGR fetuses (by 11.3+/-2.8 and 20.5+/-3.6 in control male and female fetuses, respectively; and by 22.9+/-3.1 and 38.3+/-3.4 in IUGR male and female fetuses, respectively; P
AB - Antenatal glucocorticoids are administered to mature the fetal lungs before preterm birth. Glucocorticoids also have non-pulmonary effects, including reducing fetal body and brain growth. The present study examined whether glucocorticoid administration has a sex-specific effect on growth in appropriately grown (control) and intrauterine growth-restricted (IUGR) fetal sheep. IUGR was induced at 0.7 gestation in fetal sheep by single umbilical artery ligation. On Days 5 and 6 after surgery, IUGR or control fetuses were exposed to the synthetic glucocorticoid betamethasone (BM; 11.4mg) or saline via intramuscular maternal administration. On Day 7, a postmortem was conducted to determine fetal sex and weight. Compared with control fetuses, the birthweight of male and female IUGR fetuses was significantly reduced (by 18.5+/-4.4 (P=0.002) and 21.7+/-6.0 (P=0.001), respectively). Maternal administration of BM significantly reduced bodyweight in both control and IUGR fetuses (by 11.3+/-2.8 and 20.5+/-3.6 in control male and female fetuses, respectively; and by 22.9+/-3.1 and 38.3+/-3.4 in IUGR male and female fetuses, respectively; P
UR - http://www.publish.csiro.au/?act=view_file&file_id=RD11143.pdf
U2 - 10.1071/RD11143
DO - 10.1071/RD11143
M3 - Article
VL - 24
SP - 753
EP - 758
JO - Reproduction, Fertility and Development
JF - Reproduction, Fertility and Development
SN - 1031-3613
IS - 5
ER -